Skip to main content
. 2018 Jan 9;14:95–104. doi: 10.2147/TCRM.S149325

Figure 3.

Figure 3

Nonlinear dose–response relationship between 25[OH]D concentration and risk of prostate cancer.

Abbreviations: 25[OH]D, 25-hydroxyvitamin D; RR, relative risk.